Clinical Trial

Reduction of Polypharmacy in Elderly People With Multiple Diseases

Study acronym: RED
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 9, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Elderly GP patients are often treated with five or more medications and therefore prone to adverse drug reactions (ADR). Potentially inappropriate prescriptions (PIPs) lead to increased adverse events like falls, hospitalizations and mortality. The primary aim of this study to reduce the frequency of ADRs in multimorbid patients aged 70 years and older by reducing polypharmacy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-08-31; most recent amendment 2025-01-07.
Status change: Not Yet Recruiting → Recruiting 2025-01-07
Trial Details
NCT Number NCT05526963
Lead Sponsor Martin-Luther-Universität Halle-Wittenberg
Collaborators: University of Leipzig, Hannover Medical School
Conditions Polypharmacy, Multimorbidity
Enrollment 1,146 participants
Start Date 2024-05-30
Primary Completion 2025-10-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-09